National Scleroderma Foundation: Two CAR-T Clinical Trials Paused: An Update
September 01, 2026
September 01, 2026
DANVERS, Massachusetts, Sept. 1 -- The National Scleroderma Foundation posted the following news:
* * *
Two CAR-T Clinical Trials Paused: An Update
*
National Scleroderma Foundation leadership is aware of the pause in two CAR-T clinical development programs and is closely following developments.
For people living with scleroderma, particularly those with severe disease and limited treatment options, emerging approaches such as CAR . . .
* * *
Two CAR-T Clinical Trials Paused: An Update
*
National Scleroderma Foundation leadership is aware of the pause in two CAR-T clinical development programs and is closely following developments.
For people living with scleroderma, particularly those with severe disease and limited treatment options, emerging approaches such as CAR . . .